BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 4963100)

  • 41. [Prevention and treatment of Rh. isoimmunization. Results].
    Martínez M; Lozano G; Flores F; Fernández P; Garrido G
    Acta Obstet Ginecol Hisp Lusit; 1971 Mar; 19(2):149-57. PubMed ID: 4996734
    [No Abstract]   [Full Text] [Related]  

  • 42. [Rh-incompatibility acidosis in newborn infants following intrauterine transfusion].
    Siebers JW
    Geburtshilfe Frauenheilkd; 1985 Aug; 45(8):552-3. PubMed ID: 4043707
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rhesus incompatibility in Batak Karonese, Indonesian native male infant.
    Asnil PO; Markum AH; Wahidijat I; Muslichan S; Abdulsalam M
    Paediatr Indones; 1977; 17(7-8):269-73. PubMed ID: 412161
    [No Abstract]   [Full Text] [Related]  

  • 44. Advances in prophylaxis and therapy of Rh-erythroblastosis.
    Thomsen K
    Nihon Sanka Fujinka Gakkai Zasshi; 1969 Aug; 21(8):911-2. PubMed ID: 4186822
    [No Abstract]   [Full Text] [Related]  

  • 45. Recent progress in the management of Rh isoimmunization.
    Charles AG; Alpern WM; Friedman EA
    IMJ Ill Med J; 1967 Mar; 131(3):330-5. PubMed ID: 4382668
    [No Abstract]   [Full Text] [Related]  

  • 46. Current management of hemolytic disease of the newborn infant.
    Naiman JL
    J Pediatr; 1972 Jun; 80(6):1049-59. PubMed ID: 4112666
    [No Abstract]   [Full Text] [Related]  

  • 47. [Problem of the dose of immunoglobulins in the prevention of hemolytic disease of newborn due to materno-fetal incompatibility of antigen D, in case of massive feto-maternal hemorrhage].
    Mattone PG; Meriggi E; De Martin G
    Minerva Ginecol; 1972 May; 24(7):337-41. PubMed ID: 4211573
    [No Abstract]   [Full Text] [Related]  

  • 48. [Rh isoimmunization: experience with and critical analysis of recent diagnostic and therapeutic criteria].
    Bellati U; Noia G; Garzetti GG; Serri FG; Riccardi P; Stabile A
    Ann Ostet Ginecol Med Perinat; 1981; 102(2):84-94. PubMed ID: 6167190
    [No Abstract]   [Full Text] [Related]  

  • 49. Management of the Rh-sensitized patient. A 3 year experience with amniocentesis and intrauterine transfusion.
    Stenchever MA; Cibils LA
    Am J Obstet Gynecol; 1968 Feb; 100(4):554-66. PubMed ID: 4965939
    [No Abstract]   [Full Text] [Related]  

  • 50. [Incidence of erythroblastosis in the umbilical cord blood of newborn infants with materno-fetal Rh factor incompatibility without signs of isoimmunization].
    Moscatelli P; Pantarotto F; Melevendi C
    Minerva Pediatr; 1967 Oct; 19(43):1901-2. PubMed ID: 4974603
    [No Abstract]   [Full Text] [Related]  

  • 51. Possible graft-versus-host reaction after intrauterine transfusion for Rh erythroblastosis fetalis.
    Naiman JL; Punnett HH; Lischner HW; Destiné ML; Arey JB
    N Engl J Med; 1969 Sep; 281(13):697-701. PubMed ID: 4980610
    [No Abstract]   [Full Text] [Related]  

  • 52. [JKa isoimmunization following the I.U.F.T. performed in erythroblastosis fetalis due to Rh incompatibility].
    Franchini E; Valbonesi M; Santi F; Porro E
    Ann Ostet Ginecol Med Perinat; 1975; 96(6):404-5. PubMed ID: 818933
    [No Abstract]   [Full Text] [Related]  

  • 53. Role of IVIG in preventing exchange transfusions in Rh hemolytic disease.
    Aylin T; Berkan G
    Indian Pediatr; 2005 Jan; 42(1):77-9. PubMed ID: 15695869
    [No Abstract]   [Full Text] [Related]  

  • 54. Estriol excretion with erythroblastosis.
    Mandelbaum B; Ross M; Evans TN
    Obstet Gynecol; 1970 Apr; 35(4):570-3. PubMed ID: 4985599
    [No Abstract]   [Full Text] [Related]  

  • 55. Use of maternal blood for intrauterine transfusions.
    Eyster ME; Queenan JT; Haber JM
    Obstet Gynecol; 1969 Nov; 34(5):636-40. PubMed ID: 4981597
    [No Abstract]   [Full Text] [Related]  

  • 56. [Prenatal determination of the fetal blood group].
    Meroni P; Della Torre L
    Ann Ostet Ginecol Med Perinat; 1969 Jul; 91(7):497-507. PubMed ID: 4997558
    [No Abstract]   [Full Text] [Related]  

  • 57. Intrauterine fetal transfusion in the management of Rh disease.
    Bashore RA; Lecky JW
    Obstet Gynecol; 1971 Jul; 38(1):79-85. PubMed ID: 4997962
    [No Abstract]   [Full Text] [Related]  

  • 58. Management of the severely affected Rh-isoimmunized patient.
    Stenchever MA; Parada M
    Am J Obstet Gynecol; 1971 Sep; 111(2):274-9. PubMed ID: 4999746
    [No Abstract]   [Full Text] [Related]  

  • 59. [Brain damage from blood group incompatibility].
    Rett A
    Wien Med Wochenschr; 1970 Apr; 120(15):251-3. PubMed ID: 4994455
    [No Abstract]   [Full Text] [Related]  

  • 60. [Procedure in a case of blood incompatibility with Rh specificity].
    Stockmann J
    Ther Umsch; 1971 Jul; 28(7):444-51. PubMed ID: 4999601
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.